Background: HIV testing and counselling (HTC) is a gateway into HIV prevention and treatment programs. In 2007, only 36% of persons had ever been tested for HIV. The universal access target for HIV testing in is 80% of the population. Nationally-representative data on HIV testing are important to evaluate Kenya’s progress towards reaching the universal target. Methodology: In 2012, Kenya conducted a national household survey among persons aged 18 months-64 years. Respondents aged 15-64 years were administered a questionnaire and provided blood for centralized testing. Home-based testing and counselling (HBTC), using rapid HIV testing kits based on the national HIV testing algorithm was offered to participants to learn their HIV status. Point-of-care CD4 T-cell count testing was conducted among persons testing HIV+ in HBTC. Data were weighted to account for sampling probability and adjusted for for non-response. We describe HIV testing among survey respondents aged 15-64 years. Results from HBTC are based on a subset of participants that accepted HBTC. Results: Of 13,720 adults interviewed, 71.6% (80.4% women, 62.5% men) had ever been tested for HIV. Among those, 56.1% had been tested in the past year, 69.3% had been tested more than once, and 37.2% had been tested with a sexual partner. Fifty-three percent of HIV-infected persons did not have correct knowledge of their HIV status. Incorrect knowledge of HIV positive status was higher among men [62.0%; 95% confidence interval (CI) 53.4-70.5] compared to women (47.8%; 95% CI 42.1-53.4), youth aged 15-24 years (81.0%; 95% CI 72.3-91.7) compared to persons aged 25-34 years (58.9%; 95% CI 50.5-67.4), and persons who did not use condoms with their most recent sexual partner in the past 12 months (67.7%; 95% CI 60.3-75.1 vs. 37.1%; 95% CI 29.1-45.2). Overall, 9,874 (72.0%) participants accepted HBTC. Among those, 361 (4.1%; 95% CI 3.3-4.9) tested HIV+, and of those, 94% accepted POC CD4+ T-cell count testing. Of those, the median CD4+ T-cell count was 423 cells/mm3 (interquartile range: 250-573), and 40.3% (95% CI 30.8-49.6) of those who were antiretroviral therapy (ART) naive were eligible for ART based on current national guidelines (CD4≤350 cells/mm3). Conclusions: HIV testing has improved over the last five years, nearly reaching the universal access target in Kenya. However, correct knowledge of HIV status among HIV-infected persons remains low. HTC should be expanded to reach more men and youth, and strategies are needed to increase repeat testing for persons at risk. HBTC for HIV can be successfully integrated into population-based surveys as a tool to identify persons in need of treatment. However, HIV prevalence data from HBTC will be an under-representation of national prevalence due to selective participation.